Core Viewpoint - The announcement details the first vesting results of the 2022 restricted stock incentive plan for Sino Medical Technology Co., Ltd, including the number of shares to be listed and the vesting schedule [1][5]. Group 1: Stock Listing and Vesting Details - The stock type for this listing is equity incentive shares, with a total of 2,592,000 shares to be listed for circulation [1][6]. - The listing date for these shares is set for June 23, 2025 [1][6]. - The shares are part of the first vesting results of the third vesting period of the 2022 restricted stock incentive plan [1][5]. Group 2: Decision-Making Process and Disclosure - The decision-making process for the stock vesting involved multiple meetings of the board and supervisory committee, with independent directors providing clear consent [2][4]. - The company publicly disclosed the incentive plan and related documents on the Shanghai Stock Exchange website [3][4]. Group 3: Basic Information on Stock Vesting - A total of 28 individuals are involved in this vesting, with 259,200 shares vested, representing 32% of the total granted stock [6][7]. - The shares are sourced from the company's directed issuance of A-shares to the incentive recipients [6][7]. Group 4: Impact on Financials - The newly vested shares will increase the total share capital from 413,456,000 to 416,048,000 shares, with the new shares accounting for approximately 0.6269% of the total share capital [6][7]. - The vesting of these shares is not expected to have a significant impact on the company's recent financial performance [7].
赛诺医疗: 赛诺医疗关于公司2022年限制性股票激励计划首次授予部分第三个归属期第一次归属结果暨股份上市流通的公告